Resistance to anti-VEGF therapy in neovascular age-related macular degeneration: a comprehensive review
about
Switching to aflibercept among patients with treatment-resistant neovascular age-related macular degeneration: a systematic review with meta-analysis.Exploring the cross talk between ER stress and inflammation in age-related macular degeneration.Potential role of sirtuin 1 in Müller glial cells in mice choroidal neovascularization.The potential of anti-VEGF (Vasotide) by eye drops to treat proliferative retinopathies.Delivery of CR2-fH Using AAV Vector Therapy as Treatment Strategy in the Mouse Model of Choroidal Neovascularization.Switch to Aflibercept in the Treatment of Neovascular AMD: Long-Term Results.3D endothelial cell spheroid/human vitreous humor assay for the characterization of anti-angiogenic inhibitors for the treatment of proliferative diabetic retinopathy.Clinical observations on the use of new anti-VEGF drug, conbercept, in age-related macular degeneration therapy: a meta-analysis.c-Jun-mediated microRNA-302d-3p induces RPE dedifferentiation by targeting p21Waf1/Cip1.Ranibizumab treatment history as predictor of the switch-response to aflibercept: evidence for drug tolerance.Molecular Pharmacology of VEGF-A Isoforms: Binding and Signalling at VEGFR2.Retinal and choroidal angiogenesis: a review of new targets.Efficacy Comparison of Intravitreal Anti-VEGF Therapy for Three Subtypes of Neovascular Age-Related Macular Degeneration: A Systematic Review and Meta-AnalysisRepurposing antimalarial aminoquinolines and related compounds for treatment of retinal neovascularizationInhibition of retinal angiogenesis by gold nanoparticles inducing autophagy
P2860
Q37582768-3D693951-48AA-4785-9F86-6A4D5D5A4BDFQ41105949-0C298CEE-189E-4DEF-B19A-BE0AC7C693AEQ41495461-5C38B143-A689-4A1A-B403-A2D806B96326Q42370368-F60A8C57-5E58-46B9-9E4D-19EF6C6A4FEEQ45875770-72076536-3C02-4DB9-B984-6BD523ABBB2CQ46048523-1D0047F2-4648-4A7E-8FF9-70AEBCC99C48Q48349526-FD4CD1FF-74C2-4B56-B6A0-16E6DBB4E392Q49223108-B3E614CF-0297-4C33-B727-CDDA5116B575Q52579556-3734535D-3EC8-41F1-B025-062B49018D53Q52595306-8C07F52A-C908-496B-8696-8B44B0E1036FQ52717006-DF991FA4-475F-46BF-A927-78A638A71597Q53098522-CB9D7F24-FCBC-45EE-BD43-29839718926EQ58697934-A30B24E5-BD11-4A87-BF37-C0FDCF66558DQ58747914-70CDDFE5-CA25-4CA4-87A3-2299483554DDQ58767234-F39217E8-7412-46B0-863C-6F5D971F6F5C
P2860
Resistance to anti-VEGF therapy in neovascular age-related macular degeneration: a comprehensive review
description
2016 nî lūn-bûn
@nan
2016 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2016 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2016年の論文
@ja
2016年学术文章
@wuu
2016年学术文章
@zh-cn
2016年学术文章
@zh-hans
2016年学术文章
@zh-my
2016年学术文章
@zh-sg
2016年學術文章
@yue
name
Resistance to anti-VEGF therap ...... ration: a comprehensive review
@ast
Resistance to anti-VEGF therap ...... ration: a comprehensive review
@en
Resistance to anti-VEGF therap ...... ration: a comprehensive review
@nl
type
label
Resistance to anti-VEGF therap ...... ration: a comprehensive review
@ast
Resistance to anti-VEGF therap ...... ration: a comprehensive review
@en
Resistance to anti-VEGF therap ...... ration: a comprehensive review
@nl
prefLabel
Resistance to anti-VEGF therap ...... ration: a comprehensive review
@ast
Resistance to anti-VEGF therap ...... ration: a comprehensive review
@en
Resistance to anti-VEGF therap ...... ration: a comprehensive review
@nl
P2093
P2860
P921
P3181
P356
P1476
Resistance to anti-VEGF therap ...... ration: a comprehensive review
@en
P2093
Jingke Zhao
Shiqi Yang
Xiaodong Sun
P2860
P304
P3181
P356
10.2147/DDDT.S97653
P407
P5008
P577
2016-06-02T00:00:00Z